Jeffrey Scott Sherman - 07 Dec 2025 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Financial Officer
Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
07 Dec 2025
Net transactions value
$0
Form type
4
Filing time
09 Dec 2025, 16:16:26 UTC
Previous filing
06 Aug 2025
Next filing
24 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sherman Jeffrey Scott Chief Financial Officer 9490 NEOGENOMICS WAY, FORT MYERS /s/ Ali Olivo, Attorney-in-Fact 09 Dec 2025 0001463145

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Tax liability $0 -11,938 -6.3% $0.000000 176,394 07 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 249,169 07 Dec 2025 Common Stock 249,169 $11.62 Direct F2
holding NEO Stock Option (Right to Buy) 73,016 07 Dec 2025 Common Stock 73,016 $19.65 Direct F3
holding NEO Restricted Stock Unit 13,006 07 Dec 2025 Common Stock 13,006 $0.000000 Direct F4, F5
holding NEO Performance Stock Unit 39,016 07 Dec 2025 Common Stock 39,016 $0.000000 Direct F5, F6
holding NEO Stock Option (Right to Buy) 77,913 07 Dec 2025 Common Stock 77,913 $16.45 Direct F7
holding NEO Performance Stock Unit 46,606 07 Dec 2025 Common Stock 46,606 $0.000000 Direct F5, F8
holding NEO Restricted Stock Unit 59,382 07 Dec 2025 Common Stock 59,382 $0.000000 Direct F5
holding NEO Restricted Stock Unit 31,071 07 Dec 2025 Common Stock 31,071 $0.000000 Direct F5, F9
holding NEO Stock Option (Right to Buy) 214,900 07 Dec 2025 Common Stock 214,900 $13.05 Direct F10, F11
holding NEO Restricted Stock Unit 126,476 07 Dec 2025 Common Stock 126,476 $0.000000 Direct F5, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares surrendered to NeoGenomics, Inc. for retirement to satisfy the tax obligations in connection with the December 1, 2025 vesting of restricted stock.
F2 On December 5, 2022, Mr. Sherman was granted 249,169 stock options. The options vest ratably over four years with the first tranche vesting on December 7, 2023.
F3 On May 11, 2023, Mr. Sherman was granted 73,016 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F4 On May 11, 2023, Mr. Sherman was granted 39,016 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F5 Once vested, the shares of common stock are not subject to expiration.
F6 On May 11, 2023, Mr. Sherman was granted 39,016 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 58,524. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
F7 On February 23, 2024, Mr. Sherman was granted 77,913 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F8 On February 23, 2024, Mr. Sherman was granted 46,606 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 69,910. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
F9 On February 23, 2024, Mr. Sherman was granted 46,606 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F10 This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
F11 On February 21, 2025, Mr. Sherman was granted 214,900 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F12 On February 21, 2025, Mr. Sherman was granted 126,476 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.